LEUSTATIN Side Effects

7013071-3 | Diarrhoea, Febrile Neutropenia, Gastrointestinal Inflammation, Weight Decreased
on Sep 17, 2010 Male patient from AUSTRALIA , weighting 191.8 lb, was diagnosed with hairy cell leukaemia and was treated with Leustatin (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, febrile neutropenia, gastrointestinal inflammation, weight decreased. Leustatin dosage: .

6925632-8 | Neutrophil Count Decreased, Pneumonia, Sepsis
Patient was taking Leustatin (View Usage). Patient had the following side effects: neutrophil count decreased, pneumonia (What is pneumonia?), sepsis (What is sepsis?) on Aug 12, 2010 from JAPAN Additional patient health information: Male patient , 67 years of age, was diagnosed with hairy cell leukaemia and. Leustatin dosage: 2-hour Drip Infusion.

6895679-9 | Alanine Aminotransferase Increased, Blood Albumin Decreased, Blood Potassium Decreased, Eosinophil Count Increased, Eosinophilia, Gamma-glutamyltransferase Increased, Leukopenia, Lymphocyte Count Decreased, Monocyte Count Increased
Adverse event was reported on Jul 23, 2010 by a Male patient taking Leustatin (View Usage) (Dosage: ) was diagnosed with hairy cell leukaemia, antibiotic prophylaxis, fungal infection (What is fungal infection?), pneumocystis jiroveci pneumonia, antifungal prophylaxis and. Location: JAPAN , weighting 160.9 lb, After Leustatin was administered, patient had the following side effects: alanine aminotransferase increased, blood albumin decreased, blood potassium decreased, eosinophil count increased, eosinophilia, gamma-glutamyltransferase increased, leukopenia, lymphocyte count decreased, monocyte count increased. During the same period patient was treated with MYCOSYST (View Mycosyst Review and Mycosyst Label ), COTRIM (View Cotrim Review and Cotrim Label ), ISCOTIN (View Iscotin Review and Iscotin Label ). Patient was hospitalized.

6696309-1 | Disseminated Intravascular Coagulation, Metastases To Bone Marrow
on Apr 22, 2010 Female patient from JAPAN , 76 years of age, was diagnosed with extranodal marginal zone b-cell lymphoma (malt type) and was treated with Leustatin (View Usage). Patient experienced the following unwanted or unexpected effects: disseminated intravascular coagulation, metastases to bone marrow. Leustatin dosage: On Days 2-6 (every 4 Weeks). During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).


6686380-5 | Anaemia, Blood Bilirubin Increased, Blood Uric Acid Increased, C-reactive Protein Increased, Condition Aggravated, Constipation, Dermatitis Bullous, Febrile Neutropenia, Haematocrit Decreased
on Apr 08, 2010 Male patient from JAPAN , weighting 136.7 lb, was diagnosed with hairy cell leukaemia, prophylaxis, febrile neutropenia, pyrexia, constipation (What is constipation?), herpes zoster and was treated with Leustatin (View Usage). Patient had the following side effects: anaemia, blood bilirubin increased, blood uric acid increased, c-reactive protein increased, condition aggravated, constipation (What is constipation?), dermatitis bullous, febrile neutropenia, haematocrit decreased. Leustatin dosage: . During the same period patient was treated with ITRIZOLE (View Itrizole Review and Itrizole Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), COTRIM (View Cotrim Review and Cotrim Label ), NEU UP (View Neu-up Review and Neu-up Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), VALTREX (View Valtrex Review and Valtrex Label ). Patient was hospitalized.

6674329-0 | Colon Cancer
Patient was taking Leustatin (View Usage). After Leustatin was administered, patient had the following side effects: colon cancer on Mar 31, 2010 from GREECE Additional patient health information: Female patient , 72 years of age, was diagnosed with prolymphocytic leukaemia and. Leustatin dosage: . Patient was hospitalized.

6663843-X | Alanine Aminotransferase Increased, Anaemia, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, C-reactive Protein Increased, Conjunctivitis, Decreased Appetite, Electrolyte Imbalance
Adverse event was reported on Mar 23, 2010 by a Male patient taking Leustatin (View Usage) (Dosage: ) was diagnosed with hairy cell leukaemia, upper respiratory tract inflammation, pyrexia and. Location: JAPAN , weighting 176.4 lb, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, c-reactive protein increased, conjunctivitis, decreased appetite, electrolyte imbalance. During the same period patient was treated with CRAVIT (View Cravit Review and Cravit Label ), LOXONIN (View Loxonin Review and Loxonin Label ), MINOCYCLINE HCL (View Minocycline Hcl Review and Minocycline Hcl Label ), FUNGUARD (View Funguard Review and Funguard Label ), MEROPENEM (View Meropenem Review and Meropenem Label ). Patient was hospitalized.

6600961-6 | Abnormal Behaviour, Aggression, Confusional State, Hallucination, Restlessness
on Feb 16, 2010 Male patient from GERMANY , weighting 187.4 lb, was diagnosed with hairy cell leukaemia and was treated with Leustatin (View Usage). Patient had the following side effects: abnormal behaviour, aggression, confusional state, hallucination, restlessness. Leustatin dosage: . During the same period patient was treated with KEVATRIL (View Kevatril Review and Kevatril Label ). Patient was hospitalized.

6581555-8 | Acute Myeloid Leukaemia, Dizziness, Malaise, Pancytopenia, White Blood Cell Count Decreased
on Feb 05, 2010 Male patient from JAPAN , weighting 218.3 lb, was diagnosed with b-cell lymphoma, prophylaxis against gastrointestinal ulcer and was treated with Leustatin (View Usage). After Leustatin was administered, patient had the following side effects: acute myeloid leukaemia, dizziness (What is dizziness?), malaise, pancytopenia, white blood cell count decreased. Leustatin dosage: . During the same period patient was treated with ALKYLATING AGENTS (View Alkylating Agents Review and Alkylating Agents Label ), ENDOXAN (View Endoxan Review and Endoxan Label ), RITUXAN (View Rituxan Review and Rituxan Label ), GRAN (View Gran Review and Gran Label ), GASTER D (View Gaster D Review and Gaster D Label ). Patient was hospitalized.

6505031-3 | Anaemia, Hyperkalaemia, Hypoalbuminaemia, Lymphopenia, Off Label Use
Patient was taking Leustatin (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, hyperkalaemia, hypoalbuminaemia, lymphopenia, off label use on Dec 10, 2009 from JAPAN Additional patient health information: Male patient , 56 years of age, was diagnosed with b-cell lymphoma, antifungal prophylaxis and. Leustatin dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), TRIMETHOPRIM + SULFAMETHOXAZOLE (View Trimethoprim + Sulfamethoxazole Review and Trimethoprim + Sulfamethoxazole Label ).

6505030-1 | Constipation, Hypoalbuminaemia, Hyponatraemia, Lymphopenia, Neutropenia, Off Label Use, Thrombocytopenia, Weight Increased
Adverse event was reported on Dec 10, 2009 by a Female patient taking Leustatin (View Usage) (Dosage: 0.09 Mg/ Kg Was Administered Daily In 2 Hours Intravenous Infusion For 5 Consecutive Days) was diagnosed with b-cell lymphoma, antifungal prophylaxis and. Location: JAPAN , 46 years of age, Patient had the following side effects: constipation (What is constipation?), hypoalbuminaemia, hyponatraemia, lymphopenia, neutropenia, off label use, thrombocytopenia, weight increased. During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ), TRIMETHOPRIM + SULFAMETHOXAZOLE (View Trimethoprim + Sulfamethoxazole Review and Trimethoprim + Sulfamethoxazole Label ).

6502644-X | Anaemia, Hyperkalaemia, Hypoalbuminaemia, Lymphopenia
on Dec 10, 2009 Male patient from JAPAN , 56 years of age, was diagnosed with b-cell lymphoma, antifungal prophylaxis and was treated with Leustatin (View Usage). After Leustatin was administered, patient had the following side effects: anaemia, hyperkalaemia, hypoalbuminaemia, lymphopenia. Leustatin dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), TRIMETHOPRIM + SULFAMETHOXAZOLE (View Trimethoprim + Sulfamethoxazole Review and Trimethoprim + Sulfamethoxazole Label ).

6490783-1 | Acinetobacter Infection, Diarrhoea, Hypergammaglobulinaemia Benign Monoclonal, Mesangioproliferative Glomerulonephritis, Normochromic Normocytic Anaemia, Renal Disorder, Systemic Mastocytosis
on Dec 09, 2009 Female patient from GREECE , 70 years of age, was diagnosed with systemic mastocytosis and was treated with Leustatin (View Usage). Patient experienced the following unwanted or unexpected effects: acinetobacter infection, diarrhoea, hypergammaglobulinaemia benign monoclonal, mesangioproliferative glomerulonephritis, normochromic normocytic anaemia, renal disorder, systemic mastocytosis. Leustatin dosage: . During the same period patient was treated with INTERFERON ALFA (View Interferon Alfa Review and Interferon Alfa Label ).

6473673-X | Acinetobacter Infection, Diarrhoea, Off Label Use
Patient was taking Leustatin (View Usage). Patient had the following side effects: acinetobacter infection, diarrhoea, off label use on Dec 02, 2009 from GREECE Additional patient health information: Female patient , 70 years of age, was diagnosed with systemic mastocytosis and. Leustatin dosage: . During the same period patient was treated with INTERFERON (View Interferon Review and Interferon Label ).

6466021-2 | Acute Myeloid Leukaemia, White Blood Cell Count Decreased
Adverse event was reported on Nov 24, 2009 by a Male patient taking Leustatin (View Usage) (Dosage: ) was diagnosed with b-cell lymphoma, prophylaxis against gastrointestinal ulcer and. Location: JAPAN , weighting 218.3 lb, After Leustatin was administered, patient had the following side effects: acute myeloid leukaemia, white blood cell count decreased. During the same period patient was treated with ALKYLATING AGENTS (View Alkylating Agents Review and Alkylating Agents Label ), ENDOXAN (View Endoxan Review and Endoxan Label ), RITUXAN (View Rituxan Review and Rituxan Label ), GRAN (View Gran Review and Gran Label ), GASTER D (View Gaster D Review and Gaster D Label ). Patient was hospitalized.

6458570-8 | Anaemia, Blood Alkaline Phosphatase Increased, Blood Creatinine Increased, Blood Uric Acid Increased, Deep Vein Thrombosis, Gamma-glutamyltransferase Increased, Herpes Zoster, Lymphocyte Count Decreased, Neutropenia
on Nov 13, 2009 Male patient from JAPAN , weighting 160.9 lb, was diagnosed with hairy cell leukaemia, infection (What is infection?), antifungal prophylaxis, prophylaxis against gastrointestinal ulcer and was treated with Leustatin (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, blood alkaline phosphatase increased, blood creatinine increased, blood uric acid increased, deep vein thrombosis (What is deep vein thrombosis?), gamma-glutamyltransferase increased, herpes zoster, lymphocyte count decreased, neutropenia. Leustatin dosage: . During the same period patient was treated with MEROPENEM (View Meropenem Review and Meropenem Label ), AMIKACIN SULFATE (View Amikacin Sulfate Review and Amikacin Sulfate Label ), ITRIZOLE (View Itrizole Review and Itrizole Label ), SULFAMETHOXAZOLE AND TRIMETHOPRIM (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ).

6455988-4 | Anaemia, Blood Alkaline Phosphatase Increased, Blood Creatinine Increased, Blood Uric Acid Increased, Deep Vein Thrombosis, Gamma-glutamyltransferase Increased, Herpes Zoster, Lymphocyte Count Decreased, Neutropenia
on Nov 13, 2009 Male patient from JAPAN , weighting 160.9 lb, was diagnosed with hairy cell leukaemia, infection (What is infection?), antifungal prophylaxis, prophylaxis against gastrointestinal ulcer and was treated with Leustatin (View Usage). Patient had the following side effects: anaemia, blood alkaline phosphatase increased, blood creatinine increased, blood uric acid increased, deep vein thrombosis (What is deep vein thrombosis?), gamma-glutamyltransferase increased, herpes zoster, lymphocyte count decreased, neutropenia. Leustatin dosage: . During the same period patient was treated with MEROPENEM (View Meropenem Review and Meropenem Label ), AMIKACIN SULFATE (View Amikacin Sulfate Review and Amikacin Sulfate Label ), ITRIZOLE (View Itrizole Review and Itrizole Label ), SULFAMETHOXAZOLE AND TRIMETHOPRIM (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ).

6452721-7 | Anaemia, Blood Alkaline Phosphatase Increased, Blood Creatinine Increased, Blood Uric Acid Increased, Deep Vein Thrombosis, Gamma-glutamyltransferase Increased, Herpes Zoster, Lymphocyte Count Decreased, Neutropenia
Patient was taking Leustatin (View Usage). After Leustatin was administered, patient had the following side effects: anaemia, blood alkaline phosphatase increased, blood creatinine increased, blood uric acid increased, deep vein thrombosis (What is deep vein thrombosis?), gamma-glutamyltransferase increased, herpes zoster, lymphocyte count decreased, neutropenia on Nov 13, 2009 from JAPAN Additional patient health information: Male patient , weighting 160.9 lb, was diagnosed with hairy cell leukaemia, infection (What is infection?), antifungal prophylaxis, prophylaxis against gastrointestinal ulcer and. Leustatin dosage: . During the same period patient was treated with MEROPENEM (View Meropenem Review and Meropenem Label ), AMIKACIN SULFATE (View Amikacin Sulfate Review and Amikacin Sulfate Label ), ITRIZOLE (View Itrizole Review and Itrizole Label ), SULFAMETHOXAZOLE AND TRIMETHOPRIM (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ).

6449082-6 | Acute Myeloid Leukaemia, White Blood Cell Count Decreased
Adverse event was reported on Nov 12, 2009 by a Male patient taking Leustatin (View Usage) (Dosage: ) was diagnosed with b-cell lymphoma, prophylaxis against gastrointestinal ulcer, antifungal prophylaxis and. Location: JAPAN , weighting 218.3 lb, Patient experienced the following unwanted or unexpected effects: acute myeloid leukaemia, white blood cell count decreased. During the same period patient was treated with ALKYLATING AGENTS (View Alkylating Agents Review and Alkylating Agents Label ), RITUXAN (View Rituxan Review and Rituxan Label ), GRAN (View Gran Review and Gran Label ), GASTER D (View Gaster D Review and Gaster D Label ), BAKTAR (View Baktar Review and Baktar Label ). Patient was hospitalized.

6449081-4 | B-cell Lymphoma, Dyspnoea, Local Swelling, Platelet Count Decreased, White Blood Cell Count Decreased
on Nov 17, 2009 Female patient from JAPAN , weighting 143.3 lb, was diagnosed with b-cell lymphoma and was treated with Leustatin (View Usage). Patient had the following side effects: b-cell lymphoma, dyspnoea, local swelling, platelet count decreased, white blood cell count decreased. Leustatin dosage: . During the same period patient was treated with NOVANTRONE (View Novantrone Review and Novantrone Label ).

6405140-3 | B-cell Lymphoma, Haemoglobin Decreased, Lymphocyte Count Decreased, Tumour Haemorrhage, White Blood Cell Count Decreased
on Oct 14, 2009 Female patient from JAPAN , weighting 116.8 lb, was diagnosed with b-cell lymphoma and was treated with Leustatin (View Usage). After Leustatin was administered, patient had the following side effects: b-cell lymphoma, haemoglobin decreased, lymphocyte count decreased, tumour haemorrhage, white blood cell count decreased. Leustatin dosage: . During the same period patient was treated with NOVANTRONE (View Novantrone Review and Novantrone Label ), NEUTROGIN (View Neutrogin Review and Neutrogin Label ), CONCENTRATED RED CELLS (View Concentrated Red Cells Review and Concentrated Red Cells Label ).

6368603-5 | Neuroendocrine Carcinoma Of The Skin
Patient was taking Leustatin (View Usage). Patient experienced the following unwanted or unexpected effects: neuroendocrine carcinoma of the skin on Sep 21, 2009 from POLAND Additional patient health information: Female patient , 51 years of age, was diagnosed with chronic lymphocytic leukaemia and. Leustatin dosage: . During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ).

6357430-0 | Alanine Aminotransferase Increased, Blood Albumin Decreased, Blood Potassium Decreased, Eosinophilia, Gamma-glutamyltransferase Increased, Leukopenia, Lymphocyte Count Decreased, Rash
Adverse event was reported on Sep 07, 2009 by a Male patient taking Leustatin (View Usage) (Dosage: ) was diagnosed with pneumocystis jiroveci pneumonia, tonsillar inflammation and. Location: JAPAN , weighting 160.9 lb, Patient had the following side effects: alanine aminotransferase increased, blood albumin decreased, blood potassium decreased, eosinophilia, gamma-glutamyltransferase increased, leukopenia, lymphocyte count decreased, rash (What is rash?). During the same period patient was treated with MYCOSYST (View Mycosyst Review and Mycosyst Label ), BAKTAR (View Baktar Review and Baktar Label ), ISCOTIN (View Iscotin Review and Iscotin Label ), POLARAMINE (View Polaramine Review and Polaramine Label ), NEUTROGIN (View Neutrogin Review and Neutrogin Label ), PENTCILLIN (View Pentcillin Review and Pentcillin Label ), TAZOCIN (View Tazocin Review and Tazocin Label ), AMIKACIN SULFATE (View Amikacin Sulfate Review and Amikacin Sulfate Label ). Patient was hospitalized.

6342583-0 | B-cell Lymphoma, Dyspnoea, Local Swelling, Platelet Count Decreased, White Blood Cell Count Decreased
on Sep 04, 2009 Female patient from JAPAN , weighting 143.3 lb, was diagnosed with b-cell lymphoma and was treated with Leustatin (View Usage). After Leustatin was administered, patient had the following side effects: b-cell lymphoma, dyspnoea, local swelling, platelet count decreased, white blood cell count decreased. Leustatin dosage: . During the same period patient was treated with NOVANTRONE (View Novantrone Review and Novantrone Label ).

6337394-6 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Albumin Decreased, Blood Bilirubin Increased, Diverticular Perforation, Haemoglobin Decreased, Lymphocyte Count Decreased, Neutrophil Count Decreased, Peritonitis
on Aug 20, 2008 Male patient from JAPAN , weighting 167.6 lb, was diagnosed with b-cell lymphoma and was treated with Leustatin (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood bilirubin increased, diverticular perforation, haemoglobin decreased, lymphocyte count decreased, neutrophil count decreased, peritonitis. Leustatin dosage: . During the same period patient was treated with MITOXANTRONE HYDROCHLORIDE (View Mitoxantrone Hydrochloride Review and Mitoxantrone Hydrochloride Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6329358-3 | Anaemia, Hypoalbuminaemia, Hypoproteinaemia, Lymphocyte Count Decreased, Mantle Cell Lymphoma, Platelet Count Decreased, White Blood Cell Count Decreased
Patient was taking Leustatin (View Usage). Patient had the following side effects: anaemia, hypoalbuminaemia, hypoproteinaemia, lymphocyte count decreased, mantle cell lymphoma, platelet count decreased, white blood cell count decreased on Aug 20, 2009 from JAPAN Additional patient health information: Male patient , weighting 132.3 lb, was diagnosed with mantle cell lymphoma and. Leustatin dosage: . During the same period patient was treated with RITUXAN (View Rituxan Review and Rituxan Label ). Patient was hospitalized.

6313420-5 | Agranulocytosis, Pyrexia, Rash Macular
Adverse event was reported on Aug 11, 2009 by a Female patient taking Leustatin (View Usage) (Dosage: 10 Mg/10 Ml) . Location: FRANCE , 66 years of age, After Leustatin was administered, patient had the following side effects: agranulocytosis, pyrexia, rash macular. During the same period patient was treated with ZYLORIC (View Zyloric Review and Zyloric Label ), BACTRIM (View Bactrim Review and Bactrim Label ), LEDERFOLINE (View Lederfoline Review and Lederfoline Label ). Patient was hospitalized.

6284167-9 | Anaemia, Blood Lactate Dehydrogenase Increased, C-reactive Protein Increased, Hepatic Function Abnormal, Hypertriglyceridaemia, Hypocholesterolaemia, Hyponatraemia, Leukaemia, Neutropenia
on Jul 22, 2009 Male patient from JAPAN , weighting 136.7 lb, was diagnosed with hairy cell leukaemia and was treated with Leustatin (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, blood lactate dehydrogenase increased, c-reactive protein increased, hepatic function abnormal, hypertriglyceridaemia, hypocholesterolaemia, hyponatraemia, leukaemia, neutropenia. Leustatin dosage: . During the same period patient was treated with FILGRASTIM (View Filgrastim Review and Filgrastim Label ), CONCENTRATED HUMAN BLOOD PLATELET (View Concentrated Human Blood Platelet Review and Concentrated Human Blood Platelet Label ), WASHED HUMAN RBC (View Washed Human Rbc Review and Washed Human Rbc Label ).

6272180-7 | B-cell Lymphoma, Haemoglobin Decreased, Lymphocyte Count Decreased, Tumour Haemorrhage, White Blood Cell Count Decreased
on Jul 13, 2009 Female patient from JAPAN , weighting 116.8 lb, was diagnosed with b-cell lymphoma and was treated with Leustatin (View Usage). Patient had the following side effects: b-cell lymphoma, haemoglobin decreased, lymphocyte count decreased, tumour haemorrhage, white blood cell count decreased. Leustatin dosage: . During the same period patient was treated with NOVANTRONE (View Novantrone Review and Novantrone Label ), NEUTROGIN (View Neutrogin Review and Neutrogin Label ), CONCENTRATED RED CELLS (View Concentrated Red Cells Review and Concentrated Red Cells Label ).

6253212-9 | Blood Uric Acid Increased, C-reactive Protein Increased, Dermatitis Bullous, Febrile Neutropenia, Haematocrit Decreased, Haemoglobin Decreased, Hepatic Function Abnormal, Herpes Zoster, Platelet Count Decreased
Patient was taking Leustatin (View Usage). After Leustatin was administered, patient had the following side effects: blood uric acid increased, c-reactive protein increased, dermatitis bullous, febrile neutropenia, haematocrit decreased, haemoglobin decreased, hepatic function abnormal, herpes zoster, platelet count decreased on Jun 26, 2009 from JAPAN Additional patient health information: Male patient , weighting 136.7 lb, was diagnosed with hairy cell leukaemia, prophylaxis, pyrexia, constipation (What is constipation?), herpes zoster and. Leustatin dosage: . During the same period patient was treated with ITRIZOLE (View Itrizole Review and Itrizole Label ), CIPROXAN (View Ciproxan Review and Ciproxan Label ), BAKTAR (View Baktar Review and Baktar Label ), NEU UP (View Neu-up Review and Neu-up Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), VALTREX (View Valtrex Review and Valtrex Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ). Patient was hospitalized.

6248441-4 | Anaemia, Blood Urea Increased, Lymphocyte Count Decreased, Mantle Cell Lymphoma, Pancytopenia, Platelet Count Decreased, Progressive Multifocal Leukoencephalopathy, White Blood Cell Count Decreased
Adverse event was reported on Jun 25, 2009 by a Male patient taking Leustatin (View Usage) (Dosage: ) was diagnosed with mantle cell lymphoma and. Location: JAPAN , weighting 132.3 lb, Patient experienced the following unwanted or unexpected effects: anaemia, blood urea increased, lymphocyte count decreased, mantle cell lymphoma, pancytopenia, platelet count decreased, progressive multifocal leukoencephalopathy, white blood cell count decreased. During the same period patient was treated with RITUXAN (View Rituxan Review and Rituxan Label ).

6215776-0 | Anaemia, Blood Lactate Dehydrogenase Increased, C-reactive Protein Increased, Hepatic Function Abnormal, Hypertriglyceridaemia, Hypocholesterolaemia, Hyponatraemia, Neutropenia, Platelet Count Decreased
on Jun 02, 2009 Male patient from JAPAN , weighting 136.7 lb, was diagnosed with hairy cell leukaemia and was treated with Leustatin (View Usage). Patient had the following side effects: anaemia, blood lactate dehydrogenase increased, c-reactive protein increased, hepatic function abnormal, hypertriglyceridaemia, hypocholesterolaemia, hyponatraemia, neutropenia, platelet count decreased. Leustatin dosage: . During the same period patient was treated with FILGRASTIM (View Filgrastim Review and Filgrastim Label ), CONCENTRATED HUMAN BLOOD PLATELET (View Concentrated Human Blood Platelet Review and Concentrated Human Blood Platelet Label ), WASHED HUMAN RBC (View Washed Human Rbc Review and Washed Human Rbc Label ).

6157023-4 | Anaemia, Hypoalbuminaemia, Hypoproteinaemia, Lymphocyte Count Decreased, Platelet Count Decreased, White Blood Cell Count Decreased
on Apr 07, 2009 Male patient from JAPAN , weighting 132.3 lb, was diagnosed with mantle cell lymphoma and was treated with Leustatin (View Usage). After Leustatin was administered, patient had the following side effects: anaemia, hypoalbuminaemia, hypoproteinaemia, lymphocyte count decreased, platelet count decreased, white blood cell count decreased. Leustatin dosage: . During the same period patient was treated with RITUXAN (View Rituxan Review and Rituxan Label ), NOVANTRONE (View Novantrone Review and Novantrone Label ). Patient was hospitalized.

6128010-7 | Anaemia, Blood Urea Increased, Lymphocyte Count Decreased, Mantle Cell Lymphoma, Pancytopenia, Platelet Count Decreased, Progressive Multifocal Leukoencephalopathy, White Blood Cell Count Decreased
Patient was taking Leustatin (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, blood urea increased, lymphocyte count decreased, mantle cell lymphoma, pancytopenia, platelet count decreased, progressive multifocal leukoencephalopathy, white blood cell count decreased on Mar 19, 2009 from JAPAN Additional patient health information: Male patient , weighting 132.3 lb, was diagnosed with mantle cell lymphoma and. Leustatin dosage: . During the same period patient was treated with RITUXAN (View Rituxan Review and Rituxan Label ).

6115475-X | Alanine Aminotransferase Increased, Anaemia, Anorexia, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, C-reactive Protein Increased, Conjunctivitis, Electrolyte Imbalance
Adverse event was reported on Mar 03, 2009 by a Male patient taking Leustatin (View Usage) (Dosage: ) was diagnosed with hairy cell leukaemia, upper respiratory tract inflammation, pyrexia and. Location: JAPAN , weighting 176.4 lb, Patient had the following side effects: alanine aminotransferase increased, anaemia, anorexia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, c-reactive protein increased, conjunctivitis, electrolyte imbalance. During the same period patient was treated with CRAVIT (View Cravit Review and Cravit Label ), LOXONIN (View Loxonin Review and Loxonin Label ), MINOCYCLINE HCL (View Minocycline Hcl Review and Minocycline Hcl Label ), FUNGUARD (View Funguard Review and Funguard Label ), MEROPENEM TRIHYDRATE (View Meropenem Trihydrate Review and Meropenem Trihydrate Label ). Patient was hospitalized.

6114761-7 | Anaemia, Blood Urea Increased, Lymphocyte Count Decreased, Mantle Cell Lymphoma, Pancytopenia, Platelet Count Decreased, Progressive Multifocal Leukoencephalopathy, White Blood Cell Count Decreased
on Mar 09, 2009 Male patient from JAPAN , weighting 132.3 lb, was diagnosed with mantle cell lymphoma and was treated with Leustatin (View Usage). After Leustatin was administered, patient had the following side effects: anaemia, blood urea increased, lymphocyte count decreased, mantle cell lymphoma, pancytopenia, platelet count decreased, progressive multifocal leukoencephalopathy, white blood cell count decreased. Leustatin dosage: . During the same period patient was treated with RITUXAN (View Rituxan Review and Rituxan Label ).

6097765-2 | Alanine Aminotransferase Increased, Anaemia, Aspartate Aminotransferase Increased, Enteritis Infectious, Gastric Cancer, Hypoalbuminaemia, Hypoproteinaemia, Leukopenia, Lymphopenia
on Jan 27, 2009 Male patient from JAPAN , weighting 99.21 lb, was diagnosed with mantle cell lymphoma and was treated with Leustatin (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, enteritis infectious, gastric cancer, hypoalbuminaemia, hypoproteinaemia, leukopenia, lymphopenia. Leustatin dosage: . During the same period patient was treated with MITOXANTRONE HYDROCHLORIDE (View Mitoxantrone Hydrochloride Review and Mitoxantrone Hydrochloride Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ).

6076428-3 | Anaemia, Dermatitis Bullous, Febrile Neutropenia, Hepatic Function Abnormal, Herpes Zoster, Thrombocytopenia, Toxic Skin Eruption
Patient was taking Leustatin (View Usage). Patient had the following side effects: anaemia, dermatitis bullous, febrile neutropenia, hepatic function abnormal, herpes zoster, thrombocytopenia, toxic skin eruption on Feb 02, 2009 from JAPAN Additional patient health information: Male patient , weighting 136.7 lb, was diagnosed with hairy cell leukaemia, pyrexia and. Leustatin dosage: . During the same period patient was treated with ITRIZOLE (View Itrizole Review and Itrizole Label ), CIPROXAN (View Ciproxan Review and Ciproxan Label ), BAKTAR (View Baktar Review and Baktar Label ), NEU UP (View Neu-up Review and Neu-up Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ). Patient was hospitalized.

6060535-5 | Alanine Aminotransferase Increased, Anaemia, Aspartate Aminotransferase Increased, Enteritis Infectious, Gastric Cancer, Hypoalbuminaemia, Hypoproteinaemia, Leukopenia, Lymphopenia
Adverse event was reported on Jan 27, 2009 by a Male patient taking Leustatin (View Usage) (Dosage: ) was diagnosed with mantle cell lymphoma and. Location: JAPAN , weighting 99.21 lb, After Leustatin was administered, patient had the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, enteritis infectious, gastric cancer, hypoalbuminaemia, hypoproteinaemia, leukopenia, lymphopenia. During the same period patient was treated with MITOXANTRONE HYDROCHLORIDE (View Mitoxantrone Hydrochloride Review and Mitoxantrone Hydrochloride Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ).

5959034-8 | Adenoviral Haemorrhagic Cystitis
on Nov 12, 2008 Male patient from JAPAN , 69 years of age, was diagnosed with extranodal marginal zone b-cell lymphoma (malt type), insomnia, gastritis, prophylaxis of nausea and vomiting and was treated with Leustatin (View Usage). Patient experienced the following unwanted or unexpected effects: adenoviral haemorrhagic cystitis. Leustatin dosage: . During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ), MYSLEE (View Myslee Review and Myslee Label ), GASMOTIN (View Gasmotin Review and Gasmotin Label ), KYTRIL (View Kytril Review and Kytril Label ), ITRIZOLE (View Itrizole Review and Itrizole Label ), COTRIM (View Cotrim Review and Cotrim Label ). Patient was hospitalized.

5956067-2 | Bone Marrow Failure, Pancytopenia
on Nov 14, 2008 Male patient from GERMANY , weighting 41.45 lb, was diagnosed with malignant histiocytosis, infection prophylaxis, epilepsy (What is epilepsy?) and was treated with Leustatin (View Usage). Patient had the following side effects: bone marrow failure, pancytopenia. Leustatin dosage: . During the same period patient was treated with TRIMETHOPRIM (View Trimethoprim Review and Trimethoprim Label ), AMPHOTERICIN B (View Amphotericin B Review and Amphotericin B Label ), VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ), SULFAMETHOXAZOLE (View Sulfamethoxazole Review and Sulfamethoxazole Label ).

5937592-7 | Aplastic Anaemia, Immunodeficiency, Sepsis
Patient was taking Leustatin (View Usage). After Leustatin was administered, patient had the following side effects: aplastic anaemia, immunodeficiency, sepsis (What is sepsis?) on Oct 24, 2008 from JAPAN Additional patient health information: Male patient , weighting 147.7 lb, was diagnosed with mantle cell lymphoma and. Leustatin dosage: . During the same period patient was treated with RITUXAN (View Rituxan Review and Rituxan Label ).

5932218-0 | Alanine Aminotransferase Increased, Anaemia, Aspartate Aminotransferase Increased, Blood Bilirubin Increased, Blood Creatinine Increased, Blood Lactate Dehydrogenase Increased, Blood Urea Increased, Hypoalbuminaemia, Hypoproteinaemia
Adverse event was reported on Oct 17, 2008 by a Male patient taking Leustatin (View Usage) (Dosage: ) was diagnosed with lymphocytic lymphoma, prophylaxis, infection (What is infection?), hyperuricaemia and. Location: JAPAN , weighting 105.8 lb, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood bilirubin increased, blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, hypoalbuminaemia, hypoproteinaemia. During the same period patient was treated with RITUXAN (View Rituxan Review and Rituxan Label ), COTRIM (View Cotrim Review and Cotrim Label ), FUNGUARD (View Funguard Review and Funguard Label ), MEROPEN (View Meropen Review and Meropen Label ), ZYLORIC (View Zyloric Review and Zyloric Label ), CONCENTRATED HUMAN BLOOD PLATELET (View Concentrated Human Blood Platelet Review and Concentrated Human Blood Platelet Label ). Patient was hospitalized.

5930595-8 | Bone Marrow Disorder, Convulsion, Ocular Discomfort, Pancytopenia, Partial Seizures
on Oct 23, 2008 Male patient from GERMANY , weighting 41.45 lb, was diagnosed with malignant histiocytosis, infection prophylaxis, epilepsy (What is epilepsy?) and was treated with Leustatin (View Usage). Patient had the following side effects: bone marrow disorder, convulsion, ocular discomfort, pancytopenia, partial seizures. Leustatin dosage: . During the same period patient was treated with TRIMETHOPRIM (View Trimethoprim Review and Trimethoprim Label ), AMPHOTERICIN B (View Amphotericin B Review and Amphotericin B Label ), VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ), SULFAMETHOXAZOLE (View Sulfamethoxazole Review and Sulfamethoxazole Label ).

5916125-5 | Anaemia, Anorexia, Blood Alkaline Phosphatase Increased, C-reactive Protein Increased, Electrolyte Imbalance, Gastritis, Hepatic Steatosis, Hypoalbuminaemia, Hypocalcaemia
on Oct 01, 2008 Male patient from JAPAN , weighting 154.3 lb, was diagnosed with hairy cell leukaemia, pyrexia and was treated with Leustatin (View Usage). After Leustatin was administered, patient had the following side effects: anaemia, anorexia, blood alkaline phosphatase increased, c-reactive protein increased, electrolyte imbalance, gastritis, hepatic steatosis, hypoalbuminaemia, hypocalcaemia. Leustatin dosage: . During the same period patient was treated with LOXONIN (View Loxonin Review and Loxonin Label ), MINOCYCLINE HCL (View Minocycline Hcl Review and Minocycline Hcl Label ), FUNGUARD (View Funguard Review and Funguard Label ), MEROPENEM TRIHYDRATE (View Meropenem Trihydrate Review and Meropenem Trihydrate Label ), FIRSTCIN (View Firstcin Review and Firstcin Label ). Patient was hospitalized.

5915982-6 | Accidental Overdose, Asthenia, Headache, Inflammation, Insomnia, Nausea, Oropharyngeal Pain
Patient was taking Leustatin (View Usage). Patient experienced the following unwanted or unexpected effects: accidental overdose, asthenia, headache (What is headache?), inflammation, insomnia, nausea (What is nausea?), oropharyngeal pain on Oct 03, 2008 from FRANCE Additional patient health information: Female patient , weighting 132.3 lb, was diagnosed with systemic mastocytosis and. Leustatin dosage: . During the same period patient was treated with BACTRIM FAIBLE (View Bactrim Faible Review and Bactrim Faible Label ), ZELITREX (View Zelitrex Review and Zelitrex Label ), NEULASTA (View Neulasta Review and Neulasta Label ), SPECIAFOLDINE (View Speciafoldine Review and Speciafoldine Label ), CACIT VITAMIN D3 (View Cacit Vitamin D3 Review and Cacit Vitamin D3 Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), INIPOMP (View Inipomp Review and Inipomp Label ). Patient was hospitalized.

5897386-8 | Bone Marrow Failure, Lymphoproliferative Disorder, Myelodysplastic Syndrome
Adverse event was reported on Sep 15, 2008 by a Male patient taking Leustatin (View Usage) (Dosage: ) was diagnosed with waldenstrom's macroglobulinaemia and. Location: UNITED STATES , weighting 222.2 lb, Patient had the following side effects: bone marrow failure, lymphoproliferative disorder, myelodysplastic syndrome. During the same period patient was treated with PROCRIT (View Procrit Review and Procrit Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ).

5866832-8 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Albumin Decreased, Blood Bilirubin Increased, Diverticular Perforation, Haemoglobin Decreased, Lymphocyte Count Decreased, Neutrophil Count Decreased, Peritonitis
on Aug 20, 2008 Male patient from JAPAN , weighting 167.6 lb, was diagnosed with b-cell lymphoma and was treated with Leustatin (View Usage). After Leustatin was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood bilirubin increased, diverticular perforation, haemoglobin decreased, lymphocyte count decreased, neutrophil count decreased, peritonitis. Leustatin dosage: . During the same period patient was treated with MITOXANTRONE HYDROCHLORIDE (View Mitoxantrone Hydrochloride Review and Mitoxantrone Hydrochloride Label ), DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ). Patient was hospitalized.

5844737-6 | Neuroendocrine Carcinoma Of The Skin
on Aug 05, 2008 Female patient from POLAND , 51 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Leustatin (View Usage). Patient experienced the following unwanted or unexpected effects: neuroendocrine carcinoma of the skin. Leustatin dosage: . During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ).

5753971-5 | Candidiasis, Histiocytosis Haematophagic, Infection, Pancytopenia, Pseudomonas Infection, Staphylococcal Sepsis, Urinary Tract Infection
Patient was taking Leustatin (View Usage). Patient had the following side effects: candidiasis, histiocytosis haematophagic, infection (What is infection?), pancytopenia, pseudomonas infection, staphylococcal sepsis, urinary tract infection (What is urinary tract infection?) on May 27, 2008 from FRANCE Additional patient health information: Female patient , weighting 99.21 lb, was diagnosed with skin disorder, diabetes insipidus (What is diabetes insipidus?) and. Leustatin dosage: . During the same period patient was treated with MINIRIN (View Minirin Review and Minirin Label ), URSOLVAN (View Ursolvan Review and Ursolvan Label ), ZOPHREN (View Zophren Review and Zophren Label ), SKENAN (View Skenan Review and Skenan Label ), LEXOMIL (View Lexomil Review and Lexomil Label ), DIFFU K (View Diffu K Review and Diffu K Label ), BACTRIM (View Bactrim Review and Bactrim Label ). Patient was hospitalized.